Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Escitalopram Induced SIADH in an Elderly Female: A Case Study
1
x
$
30.00
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
1
x
$
30.00
Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
1
x
$
30.00
Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
1
x
$
30.00
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
1
x
$
30.00
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
1
x
$
30.00
Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain
1
x
$
30.00
Catatonia and CPK Elevation in Neurosyphilis
1
x
$
30.00
Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis
2
x
$
30.00
Antipsychotics Case Study by Yuan-Hwa Chou
1
x
$
30.00
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
1
x
$
30.00
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
1
x
$
30.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
1
x
$
30.00
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
1
x
$
30.00
A Comprehensive Update of Adhesive Capsulitis and Minimally Invasive Treatment Options
1
x
$
30.00
Predictors of Non-Stabilization during the Combination Therapy of Lithium and Divalproex in Rapid Cycling Bipolar Disorder: A Post-hoc Analysis of Two Studies
1
x
$
30.00
Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder
1
x
$
30.00
View Cart
Checkout
Home
ms
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Sale!
VOL 3 No. 1 Full Issue – January 2001
$
30.00
Original price was: $30.00.
$
20.00
Current price is: $20.00.
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 3 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Psychopharmacology Bulletin VOL 37 Supplement No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Page load link
Go to Top
